Clinical Trials Directory

Trials / Completed

CompletedNCT01650051

Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

A Double-Blind, Randomized, Multi-Center, Parallel-Group, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
424 (actual)
Sponsor
Amneal Pharmaceuticals, LLC · Industry
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective is to evaluate the safety and efficacy of Phenazopyridine HCl Tablets, USP 200 mg as a short term analgesic treatment of pain upon urination associated with Uncomplicated Urinary Tract Infections (uUTI). The secondary exploratory objective is to evaluate safety and efficacy of Phenazopyridine HCl Tablets, USP 200 mg as a short term analgesic treatment of burning upon urination associated with uUTI.

Detailed description

Subjects will make separate self-assessments for severity of pain and burning upon urination using the NRS and self-assessments of their discomfort using the GSAS at designated intervals for 24 hours. Subjects will rate the effectiveness of the study medication using the SASMS at a designated interval for 24 hours.

Conditions

Interventions

TypeNameDescription
DRUGPlacebo of Phenazopyridine Hydrochloride Tables, USP 200 mgDeep brown maroon colored, film coated round biconvex tablet debossed 'AN" obve '2' on one side and plain on the other side.
DRUGPhenazopyridine Hydrochloride Tables, USP 200 mgDeep brown maroon colored, film coated round biconvex tablet debossed 'AN" obve '2' on one side and plain on the other side.

Timeline

Start date
2012-02-01
Primary completion
2013-02-01
Completion
2014-02-01
First posted
2012-07-26
Last updated
2014-06-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01650051. Inclusion in this directory is not an endorsement.